SIPP grows 6% in a month - tremendous!

Since my last post on 28th April when the SIPP was valued at £130,800 (including cash of £1,937) the performance - along with that of the FTSE100 - has been tremendous. At close-of play on Friday 26th May, the SIPP value was £139,471 (including cash of £2,861); that's 6.6% growth in a month. Okay, that increase of £8,671 includes my monthly contribution of £750 but, even so, £7,921 is still 6% growth.

The current holdings are:

1) BAE (BA.) : 1095 shares - up 4.39% to close at 665.50 

2) BlackRock Smaller Co IT (BRSC) : 1170 shares - up 9.16% to close at 1248.00

3) G4S (GFS) : 2023 shares - up 6.84% to close at 328.00

4) GlaxoSmithKline (GSK) : 393 shares - up 4.95% to close at 1643.50
5) GVC Holdings (GVC) : 1017 shares - up 8.70% to close at 812.00
6) Imperial Brands (IMB) : 170 shares - DOWN 4.35% to close at 3680.50
7) JPMorgan Emerging Markets (JMG): 625 shares - up 4.72% to close at 797.00
8) Lancashire Holdings (LRE) : 1209 shares - NO CHANGE at 689.00
9) Legal & General (LGEN): 2396 shares - DOWN 4.14% to close at 250.20
10) Pacific Assets (PAC) : 1912 shares - up 3.59% to close at 259.00
11) Paysafe (PAYS) : 8000 shares - up 7.97% to close at 494.50

12) Sage Group (SGE): 925 shares - up 7.37% to close at 713.50

13) Schroder Asia-Pacific (SDP) : 1252 shares - up 6.30% to close at  383.50

14) Segro (SGRO) : 1607 shares - NO CHANGE at 490.70

15) Senior (SNR) : 1560 shares - up 9.70% to close at 237.40

Dividends have been reinvested resulting in increased holdings with GSK, LRE, and SGRO. 

Currently, I'm about 5 months behind my original SIPP projection made back in August 2012 - based on an annual growth of 20% - which targeted a fund value at my 65th birthday in November 2014 of £640,000. I have since downgraded that projection to £500,000 (based on annual growth of 15%) but, right now, things are looking a lot better than they were.

I know this rate of growth cannot go on indefinitely, but I'm hopeful that SGRO will see more growth this year especially when promoted to the FTSE100 index (which is almost certain). The state of the World should see sustained, long-term growth for BA., SNR and GFS; the trio of SGE, PAYS, and GVC all look strong long-term growth plays too.  The only disappointment has been IMB as the demand for cigarettes seems to finally be on the wane. 

I was considering disposing and replacing a couple of holdings this time last month, and they were IMB and GSK, but I've held on to them both and will continue to hold for the time being.  I always thinks it is better to be in the market than out.